Gadavist 10 mmol/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FCM6W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,098
Award facts
- Contract value 100% obligated
- $7,098.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Gadavist 10 mmol/10 mL vials with a ceiling value of $7,098.02. This is a firm fixed-price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. Through the DLA Troop Support Medical contract vehicle, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is currently planning the next generation of Pharmaceutical Prime Vendor Global Program contracts with multiple anticipated awards to different regional contractors.
Quick answers
Who was awarded contract SPE2DR26FCM6W?
SPE2DR26FCM6W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FCM6W worth?
The government has obligated $7,098 on SPE2DR26FCM6W.
Is contract SPE2DR26FCM6W an order under another contract?
Yes. SPE2DR26FCM6W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCM6W competed?
The extent of competition for SPE2DR26FCM6W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award